Pottier, C.; Fresnais, M.; Gilon, M.; Jérusalem, G.; Longuespée, R.; Sounni, N.E.
Tyrosine Kinase Inhibitors in Cancer: Breakthrough and Challenges of Targeted Therapy. Cancers 2020, 12, 731.
https://doi.org/10.3390/cancers12030731
AMA Style
Pottier C, Fresnais M, Gilon M, Jérusalem G, Longuespée R, Sounni NE.
Tyrosine Kinase Inhibitors in Cancer: Breakthrough and Challenges of Targeted Therapy. Cancers. 2020; 12(3):731.
https://doi.org/10.3390/cancers12030731
Chicago/Turabian Style
Pottier, Charles, Margaux Fresnais, Marie Gilon, Guy Jérusalem, Rémi Longuespée, and Nor Eddine Sounni.
2020. "Tyrosine Kinase Inhibitors in Cancer: Breakthrough and Challenges of Targeted Therapy" Cancers 12, no. 3: 731.
https://doi.org/10.3390/cancers12030731
APA Style
Pottier, C., Fresnais, M., Gilon, M., Jérusalem, G., Longuespée, R., & Sounni, N. E.
(2020). Tyrosine Kinase Inhibitors in Cancer: Breakthrough and Challenges of Targeted Therapy. Cancers, 12(3), 731.
https://doi.org/10.3390/cancers12030731